Rwanda

in page functions
Total population (2012)11,271,786
Birth cohort (2012)459,709
Surviving Infants (surviving to 1 year per year, 2012)416,688
Infant mortality rate (deaths < 1 year per 1000 births, 2011)38.10/1000
Child mortality rate (deaths < 5 years per 1000 births, 2011)54.10/1000
World Bank Index, IDA (2012)3.84
Gross Nation Income (per capita US$, 2011)570
Co-financing status (2012)Low-income
No. of districts/territories (2011)30
Download this page as a PDF factsheet

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Rwanda

Type of support

Approvals

2001-2016 (US$)
(30 Apr 2013)

Commitments

2001-2016 (US$)
(30 Apr 2013)

Disbursements

2001-2012 (US$)
(30 Apr 2013)

% Disbursed

(30 Apr 2013)
20012002200320042005200620072008200920102011201220132014201520162017
Health System Strengthening (HSS)$10,044,957$15,944,970$5,605,00056%
HPV (NVS)$2,128,000$7,563,000
Immunisation Services Support (ISS)$2,958,700$3,155,700$2,958,700100%
Injection Safety Support (INS)$369,500$369,500$369,500100%
Measles-Rubella (NVS)$3,549,500$3,549,500$3,847,942108%
MR - Operational costs (OPC)$3,279,500$3,279,500$3,279,500100%
Penta (NVS)$40,128,454$45,444,954$40,740,366102%
Pneumo (NVS)$18,741,533$31,098,533$17,361,53293%
Rotavirus (NVS)$13,346,000$24,708,500$10,249,75077%
Vaccine Introduction Grant$1,065,650$1,065,650$766,15072%
Total$95,611,795$136,179,808$85,178,441

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Rwanda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2011)

Grade of Confidence		97%

**
DTP3 - Official country estimates (2011)97%
M:F sex ratio at birth (2012)1.01
Household survey: DTP3 coverage for male (2009)97.10%
Household survey: DTP3 coverage for female (2009)96.50%
Household survey: Last DTP3 survey (2009)97%
% districts achieving > 80% DTP3 coverage (2011)60%
% districts achieving < 50% DTP3 coverage (2011)0%
MCV WHO/UNICEF estimates (2011)95%
Polio WHO/UNICEF estimates (2011)93%

Breakdown of support

Non-vaccine supportVaccine support
15% 85%
$12,978,850 $72,199,590

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Rwanda

14 May 2013

Mariam

Kenya first country to protect girls against cervical cancer with GAVI support

Kenya becomes the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.

08 May 2013

GAVI HPV Vaccine Infographic

Millions of girls in developing countries to be protected against cervical cancer thanks to new HPV vaccine deals

Historic agreements show power of innovative public-private partnership

20 March 2013

Rwanda measles-rubella vaccine campaign

Rwanda, through the supporters of GAVI Alliance, WHO, UNICEF and other members of the Measles-rubella Initiative, is rolling out a new dual measles-rubella vaccine aimed at immunising 5 millon children. This is the story 37 year old Giovance,mother of five, and her decision to get all her children immunised with the MR vaccine.

Useful links

View all sources for data in this page
close icon

modal window here